A phase I/II study of pixantrone (BBR 2778) [Cell Therapeutics] in combination with cyclophosphamide, vincristine and prednisone in patients with relapsed aggressive non-Hodgkin's lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 04 Apr 2011
At a glance
- Drugs Cyclophosphamide; Pixantrone; Prednisone; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2011 Results have been published in Leukaemia & Lymphoma, according to a Cell Therapeutics media release.
- 19 Jan 2007 Status change
- 18 Nov 2005 New trial record.